Premium
Letter: online search trends suggest patient concerns around immunosuppression use in inflammatory bowel disease during COVID‐19 in the United Kingdom
Author(s) -
Quraishi Mohammed Nabil,
Segal Jonathan P.,
Cooney Rachel,
Kennedy Nicholas A.,
Ainley Rachel,
Sharma Naveen,
Bhala Neeraj B.,
Brookes Matthew J.
Publication year - 2020
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15951
Subject(s) - medicine , immunosuppression , covid-19 , inflammatory bowel disease , intensive care medicine , disease , medline , inflammatory bowel diseases , coronavirus infections , family medicine , immunology , pathology , infectious disease (medical specialty) , outbreak , political science , law
LINKED CONTENT This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804